Efiloğlu, Ö., Başok, B. İ., Turan, T., Toprak, T., Erol, B., Çaşkurlu, T., & Yıldırım, A. (2020). Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer. Turk J Urol.
Chicago Style CitationEfiloğlu, Özgür, Banu İşbilen Başok, Turgay Turan, Tuncay Toprak, Bülent Erol, Turhan Çaşkurlu, i Asıf Yıldırım. "Role of Serum and Urine Transforming Growth Factor Beta 1, Matrix Metallopeptidase 9, Tissue Inhibitor of Metalloproteinase 2, and Nerve Growth Factor Beta Levels and Serum Neutrophil-to-lymphocyte Ratio in Predicting Recurrence and Progression Risks in Patients With Primary Non-muscle Invasive Bladder Cancer." Turk J Urol 2020.
Cita MLAEfiloğlu, Özgür, et al. "Role of Serum and Urine Transforming Growth Factor Beta 1, Matrix Metallopeptidase 9, Tissue Inhibitor of Metalloproteinase 2, and Nerve Growth Factor Beta Levels and Serum Neutrophil-to-lymphocyte Ratio in Predicting Recurrence and Progression Risks in Patients With Primary Non-muscle Invasive Bladder Cancer." Turk J Urol 2020.